CN111074009B - 一种快速检测2019-nCoV复制试剂盒及应用 - Google Patents
一种快速检测2019-nCoV复制试剂盒及应用 Download PDFInfo
- Publication number
- CN111074009B CN111074009B CN202010161635.5A CN202010161635A CN111074009B CN 111074009 B CN111074009 B CN 111074009B CN 202010161635 A CN202010161635 A CN 202010161635A CN 111074009 B CN111074009 B CN 111074009B
- Authority
- CN
- China
- Prior art keywords
- primer
- ncov
- detection
- seq
- replication
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 51
- 230000010076 replication Effects 0.000 title claims abstract description 20
- 241001678559 COVID-19 virus Species 0.000 title claims abstract 11
- 230000003321 amplification Effects 0.000 claims abstract description 13
- 238000002844 melting Methods 0.000 claims abstract description 13
- 230000008018 melting Effects 0.000 claims abstract description 13
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 13
- 238000006243 chemical reaction Methods 0.000 claims description 19
- 239000002773 nucleotide Substances 0.000 claims description 12
- 125000003729 nucleotide group Chemical group 0.000 claims description 12
- 239000000523 sample Substances 0.000 claims description 12
- 238000010839 reverse transcription Methods 0.000 claims description 10
- 238000011529 RT qPCR Methods 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 9
- 238000012360 testing method Methods 0.000 claims description 8
- 239000013641 positive control Substances 0.000 claims description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- 239000007850 fluorescent dye Substances 0.000 claims description 6
- 239000013642 negative control Substances 0.000 claims description 6
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 5
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 5
- 230000007062 hydrolysis Effects 0.000 claims description 5
- 238000006460 hydrolysis reaction Methods 0.000 claims description 5
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 claims description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000002299 complementary DNA Substances 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 2
- 241000700605 Viruses Species 0.000 abstract description 12
- 108020004707 nucleic acids Proteins 0.000 abstract description 9
- 102000039446 nucleic acids Human genes 0.000 abstract description 9
- 150000007523 nucleic acids Chemical class 0.000 abstract description 9
- 238000000034 method Methods 0.000 abstract description 7
- 208000015181 infectious disease Diseases 0.000 abstract description 4
- 244000052769 pathogen Species 0.000 abstract description 4
- 238000004458 analytical method Methods 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 238000003745 diagnosis Methods 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 9
- 241000711573 Coronaviridae Species 0.000 description 7
- 230000000241 respiratory effect Effects 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 241000112286 Bat SARS-like coronavirus Species 0.000 description 4
- 241000112287 Bat coronavirus Species 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 4
- 241000008910 Severe acute respiratory syndrome-related coronavirus Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000003753 real-time PCR Methods 0.000 description 4
- 241000315672 SARS coronavirus Species 0.000 description 3
- 239000012295 chemical reaction liquid Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000002247 constant time method Methods 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 241000588626 Acinetobacter baumannii Species 0.000 description 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
- 241000124740 Bocaparvovirus Species 0.000 description 1
- 208000025721 COVID-19 Diseases 0.000 description 1
- 241001647372 Chlamydia pneumoniae Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 241000711467 Human coronavirus 229E Species 0.000 description 1
- 241000482741 Human coronavirus NL63 Species 0.000 description 1
- 241001428935 Human coronavirus OC43 Species 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 241000713196 Influenza B virus Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- 241000351643 Metapneumovirus Species 0.000 description 1
- 241000127282 Middle East respiratory syndrome-related coronavirus Species 0.000 description 1
- 208000034486 Multi-organ failure Diseases 0.000 description 1
- 208000010718 Multiple Organ Failure Diseases 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- -1 Tris saturated phenol Chemical class 0.000 description 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000011157 hong shi Nutrition 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000000464 low-speed centrifugation Methods 0.000 description 1
- 238000011880 melting curve analysis Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 1
- 210000001989 nasopharynx Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000036303 septic shock Effects 0.000 description 1
- 208000026425 severe pneumonia Diseases 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010161635.5A CN111074009B (zh) | 2020-03-10 | 2020-03-10 | 一种快速检测2019-nCoV复制试剂盒及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010161635.5A CN111074009B (zh) | 2020-03-10 | 2020-03-10 | 一种快速检测2019-nCoV复制试剂盒及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111074009A CN111074009A (zh) | 2020-04-28 |
CN111074009B true CN111074009B (zh) | 2020-11-20 |
Family
ID=70324647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010161635.5A Active CN111074009B (zh) | 2020-03-10 | 2020-03-10 | 一种快速检测2019-nCoV复制试剂盒及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111074009B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230383368A1 (en) * | 2020-07-27 | 2023-11-30 | Microbio Pty Ltd | A detection method for viral replication |
-
2020
- 2020-03-10 CN CN202010161635.5A patent/CN111074009B/zh active Active
Non-Patent Citations (5)
Title |
---|
15例COVID-19患者治疗后痰、粪便标本新型冠状病毒核酸检测结果比较;李宝林等;《中国感染控制杂志》;20200309;239-244 * |
2019 新型冠状病毒核酸检测的研究状况与应用探讨;王旭东等;《临床检验杂志》;20200302;第38卷(第2期);81-84 * |
新型冠状病毒与实时荧光RT-PCR核酸检测;郭晓波等;《陕西医学杂志》;20200226;264-266 * |
新型冠状病毒实验室核酸检测方法及实践;匡慧慧等;《中华医院感染学杂志》;20200223;830-833 * |
新型冠状病毒肺炎病例多种生物样本的病毒核酸检测结果;施绍瑞等;《华西医学》;20200218;132-136 * |
Also Published As
Publication number | Publication date |
---|---|
CN111074009A (zh) | 2020-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111254228B (zh) | 一种检测新型冠状病毒和流感病毒的试剂盒 | |
CN111020064B (zh) | 新型冠状病毒ORF1ab基因核酸检测试剂盒 | |
CN111004870A (zh) | 新型冠状病毒n基因核酸检测试剂盒 | |
JP2012080884A (ja) | 核酸検出 | |
CN111074010B (zh) | 一种快速检测2019-nCoV核酸试剂盒及应用 | |
US20210404023A1 (en) | Novel coronavirus duplex detection kit | |
CN110578017A (zh) | 一种同步检测二十三种呼吸道病原体的试剂盒及其检测方法 | |
CN103725798B (zh) | 用于以rt-lamp法检测肾综合征出血热病毒的引物、试剂盒、检测方法 | |
WO2023087868A1 (en) | Compositions, kits, methods for detecting and identifying pathogens that cause respiratory tract infections and use thereof | |
CN111206121A (zh) | 一种用于检测新型冠状病毒orflab和S基因的试剂盒 | |
CN112359145A (zh) | 快速检测甲型流感、乙型流感和新型冠状病毒的多重引物及试剂盒 | |
CN102534051B (zh) | 一种肠道病毒检测试剂盒 | |
CN111074009B (zh) | 一种快速检测2019-nCoV复制试剂盒及应用 | |
CN113930547A (zh) | 猪流行性腹泻病毒n基因的rt-raa荧光法检测引物对、试剂盒及检测方法 | |
KR20230007464A (ko) | 호흡기 병원체 검출을 위한 검체수송 키트 및 이를 이용한 호흡기 병원체 검출방법 | |
CN112662808A (zh) | 一种新型冠状病毒covid-19核酸检测试剂盒及其检测方法 | |
CN112226539A (zh) | 一种诺如病毒核酸检测试剂盒 | |
CN111549150A (zh) | 一种用于检测肺炎克雷伯菌的试剂盒和方法 | |
CN114058742B (zh) | 一种引物探针组合物、包含其的试剂盒及其检测方法 | |
CN116121439A (zh) | 一种多重定量pcr检测真菌的方法以及试剂盒 | |
CN111996288A (zh) | 检测冠状病毒的组合物、试剂盒和方法 | |
CN112662811A (zh) | 一种新型冠状病毒4基因区段多重核酸检测试剂盒及其应用 | |
CN111172320A (zh) | 呼吸道合胞病毒f基因的检测引物、试剂盒及方法 | |
CN111500777A (zh) | 一种基于荧光rt-pcr方法检测新型冠状病毒核酸的试剂盒 | |
CN111893213A (zh) | 用于新型冠状病毒快速筛查鉴定的引物及试剂盒和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A rapid detection kit for 2019 ncov replication and its application Effective date of registration: 20211214 Granted publication date: 20201120 Pledgee: Yantai financing guarantee Group Co.,Ltd. Pledgor: BINZHOU MEDICAL University Registration number: Y2021980014859 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20201120 Pledgee: Yantai financing guarantee Group Co.,Ltd. Pledgor: BINZHOU MEDICAL University Registration number: Y2021980014859 |